Compare Vanguard Total Bond Market Index Fund ETF (BND) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Total Bond Market Index Fund ETF vs DexCom, Inc. — how do they compare? Vanguard Total Bond Market Index Fund ETF trades at $72.3, while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is trading nearer its 52-week high, Vanguard Total Bond Market Index Fund ETF nearer its low. Which is the better fit depends on your goals.
| BND | DXCM | |
|---|---|---|
52-Week High | $75.17 | $89.53 |
52-Week Low | $72.15 | $54.84 |
Market Cap | — | $33.79B |
Sector | — | Health |
Enterprise Value | — | $33.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Total Bond Market Index Fund ETF
This index measures the performance of a wide spectrum of public, investment-grade, taxable, fixed income securities in the US, including government, corporate, and international dollar-denominated bonds, as well as mortgage-backed and asset-backed securities-all with maturities of more than 1 year. All of the fund's investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the index.
Read more on BND →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
